Prismx Global Ventures Limited

Financial Services — Capital Markets · NSE

₹0.63+₹0.04 (+6.78%)

DalalBaazaar Score

68 / 100

🟢 Good

Verdict

NEUTRAL

Risk

High

Driven by negative free cash flow, micro-cap size, which brings thin liquidity, falling profits.

In simple words: The business is earning a fairly low return on the money invested in it, but sales are shrinking. Cash generation is currently the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:07 pm

Caution warranted. Multiple fundamental metrics — flagged in red below — point to either valuation stretch, leverage risk, or weakening profitability. This doesn't mean avoid the stock outright, but it does mean the burden of proof is on the growth story to justify the current price.

Understanding the Business

Company site ↗

The 60-second version of Prismx Global Ventures Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Prismx Global Ventures Limited trades in commodities, shares, and securities in India. The company operates through Trading and Finance Business segment. It also offers digital media and financial investment services.

IndustryCapital Markets

SectorFinancial Services

Employees9

Annual revenue₹9 Cr

How does it make money?

Turns over ₹9 Cr a year. Of every ₹100 of sales, about ₹64 reaches shareholders as profit, with ₹38 left at the operating level before interest, tax and depreciation. Each of its 9 employees supports ₹1.05 Cr of revenue a year, the signature of a capital- or asset-led business.

EBITDA margin38.5%

Net margin64.3%

Revenue / employee₹1.05 Cr

Who are its competitors?

The closest listed comparisons in its industry are BAJAJ FINANCE LIMITED, HDFC LIFE INS CO LTD, SBI LIFE INSURANCE CO LTD. These are the companies its valuation and returns are measured against elsewhere in this report.

BAJAJ FINANCE LIMITEDP/E 30.2x · ROE 17.8%

HDFC LIFE INS CO LTDP/E 58.4x · ROE 11.3%

SBI LIFE INSURANCE CO LTDP/E 63.9x · ROE 13.7%

What is its competitive advantage?Not assessable from these ratios

For a lender, returns on capital are shaped by leverage and funding cost rather than by pricing power, so the usual financial signature of an advantage does not apply. Judge this one on deposit franchise, cost of funds and asset quality — none of which are in this data.

ROCE4.7%

ROE8.0%

Peer median ROE13.7%

What has been driving growth?

Profit has moved mainly because margins changed, not because the business sold much more. Over 3 years revenue moved -3% while net margin moved +53% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect-3%

Margin effect+53%

DalalBaazaar Score

68/ 100

Good

Weighted across six categories. Every point is explained below.

✗ Revenue has contracted at 1.1% a year
• Profit CAGR of 13.8%
✗ Latest-year revenue growth of -95.8% is below the longer-term trend — momentum is fading
✗ Profit fell 75.8% in the latest year

Quality vs. Valuation

Company Quality

68/ 100

Good

How good the business is, ignoring the share price entirely.

Valuation

88/ 100

Cheap

What you are being asked to pay, ignoring how good the business is.

A good business currently available at an undemanding price — the combination this framework is built to look for.

Historical Valuation

Current P/E

5.7x

Sector Median

58.4x

median of 3 sector peers

🟢Against its sector it trades 90% below the peer median of 58.4x.

vs. its own history

Not enough price and earnings history

vs. sector peers

Cheap

58.4x median of 3 peers · -90%

vs. generic bands

Cheap

Below 15x

P/E (Trailing)

5.7x

P/B

0.36x

EV/EBITDA

7.2x

PEG

0.41

Dividend Yield

None

What's Good / What's Bad

🟢 What's Going Well1

Return on equity is rising
ROE has improved from 3.6% to 8.0%.

🔴 What Needs Attention1

Margins are compressing
EBITDA margin has slipped from 42.2% to 38.5% over 3 years.

Red Flags

1 item require attention · 1 watch

🟡Margins are compressingFinancial
EBITDA margin is down 3.7 points over 3 years.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Cheaper than its peers
It trades 90% below the sector median. Either the market sees a problem the numbers do not show, or the discount closes.

🔴 Bear CaseWhat could go wrong?

Margins are being competed away
EBITDA margin has fallen from 42.2% to 38.5%. If the trend continues, profit falls even on flat sales — and margin decline rarely reverses quickly.
Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1EBITDA margin holds above 36%✓ 38.5%
Two points below today's level — enough room for noise, tight enough to catch real compression.
2Return on equity stays above 8%✗ 8.0%
For a lender this is the cleanest single read on whether the book is being grown profitably.

Investment Checklist

5 / 10 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✓ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✓ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✗ Revenue growing year-over-year
✗ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high

Price history

Quick Metrics

4 good · 2 neutral · 5 weak

Market Cap

₹28 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

5.7x

Cheap

Cheap against the generic band

P/B Ratio

0.36x

Reasonable

Reasonable against the company's book value

EPS (TTM)

₹0.11

Profitable

Profitable on a per-share basis

ROE

8.0%

Weak

Weak capital efficiency

ROCE

4.7%

Weak

Low return on total capital employed

Debt/Equity

0.10x

Low

Conservative leverage

Revenue Growth (YoY)

-95.8%

Shrinking

Sales are contracting

Profit Growth (YoY)

-75.8%

Falling

Profits are shrinking

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

-₹5 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

CMP

₹0.63

Operating Margin

-13.9%

Weak

Thin margins leave little room for error

Net Margin

85.4%

Good

Strong bottom-line conversion

Current Ratio

1229.00

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

0.00

Defensive

Steadier than the market

52W Range Position

77%

Mid-range

Technical Snapshot

RSI (14)

68.0

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹10 Cr	₹7 Cr	₹10 Cr	₹9 Cr	-1.1%
EBITDA	₹4 Cr	₹5 Cr	₹3 Cr	₹4 Cr	-4.1%
EBITDA Margin	42.2%	70.3%	29.4%	38.5%	—
PAT (Net Profit)	₹4 Cr	-₹17 Cr	₹1 Cr	₹6 Cr	+13.8%
EPS	₹0.09	₹-0.38	₹0.01	₹0.14	+15.9%
ROE	3.6%	-17.0%	0.7%	8.0%	—
ROCE	4.4%	-16.1%	2.0%	4.7%	—
Total Debt	₹4 Cr	₹1 Cr	₹8 Cr	₹0 Cr	-73.8%
Free Cash Flow	-₹11 Cr	₹1 Cr	₹10 Cr	-₹5 Cr	—

🟡 Revenue has been broadly flat over 3 years (-1.1% a year).

🔴 EBITDA has shrunk at 4.1% a year over 3 years.

🔴 EBITDA Margin has fallen from 42.2% to 38.5% over 3 years (-3.7 pts).

🟢 PAT (Net Profit) has grown at 13.8% a year over 3 years.

🟢 EPS has grown at 15.9% a year over 3 years.

🟢 ROE has risen from 3.6% to 8.0% over 3 years (+4.4 pts).

🟡 ROCE has held roughly flat at 4.7% over 3 years.

🟢 Total Debt has shrunk at 73.8% a year over 3 years.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹76 Cr

Total Liabilities

₹0 Cr

Total Debt

₹0 Cr

Cash & Equivalents

₹1 Cr

Operating Cash Flow

-₹5 Cr

Capex

—

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

20.9%

Peer Comparison

Company	P/E	ROE
BAJAJ FINANCE LIMITED	30.2x	17.8%
HDFC LIFE INS CO LTD	58.4x	11.3%
SBI LIFE INSURANCE CO LTD	63.9x	13.7%

Recent News

1 negative5 general

Prismx Global Ventures Ltd. Shareholding Pattern – Promoters, FIIs & DIIs

Value Research, 08 Oct

PRISMX Stock Price and Chart — NSE:PRISMX

TradingView, 17 Aug

Prismx Global Ventures secretarial auditor resigns

scanx.trade, 12 JunManagement

🔴Potentially negativeA senior departure, and an auditor's resignation especially, is worth understanding before anything else in this report.

Prismx Global Ventures Ltd. Share Price Live Today

CNBC TV18, 03 Jan

Prismx Global Ventures Ltd. Key Financial Ratios – Valuation, Profitability & More

Value Research, 27 Aug

Prismx Global AGM adopts FY26 financials, approves director changes

scanx.trade, 29 Sept

Watch Items

Revenue growth is negative (-95.8%) on the latest reported period — check if this is one-off or a trend.
This is a financial-sector business: borrowing is its raw material, not leverage in the usual sense. Debt/Equity and ROCE here aren't comparable to a manufacturer's — read them alongside NIM, GNPA and capital adequacy from the company's own disclosures.
Cross-check against the company's latest quarterly filing / investor presentation before acting.

DalalBaazaar Thesis

🟢Business QualityStrong15.9/20

🟢Financial HealthStrong17/20

🔴GrowthWeak7.7/20

🟢ProfitabilityStrong10/15

🟢ValuationAttractive13/15

🔴RiskHigh4/10

Attractive on both counts

A good business currently available at an undemanding price — the combination this framework exists to look for. The work left is qualitative: whether the advantage the numbers imply is one you can identify and expect to last.

This thesis breaks if

✓EBITDA margin holds above 36%38.5%
✗Return on equity stays above 8%8.0%